
Lymphoma Management Updates for 2021 - SPOC
This lecture will review some of the new drugs recently FDA approved for management of lymphoma such as CAR-T therapy for relapsed/refractory Mantle Cell Lymphoma or follicular lymphoma. For rel/ref DLBCL, polatuzumab vedotin in combination with bendamustine and rituximab as well as tafasitamab plus lenalidomide have been approved in recent years. We will review the data and outcomes.
Target Audience
These courses are intended for medical, radiation, and surgical oncologists, hematologists, advanced practice nurses, registered nurses, physician assistants, radiologic technologists, researchers, pharmacists, trainees, allied health personnel, and others who are interested in care for patients and survivors in North Carolina.
Learning Objectives
- Identify new indications for CAR-T therapy: rel/ref Mantle cell and follicular lymphoma
- Discuss mechanism of action of polatuzumab vedotin
- Recall long-term data for use of tafasitimab + lenalidomide in rel/ref DLBCL
Taking the Course
To continue, click the button Take Course.
If you do not see the button, please ensure that you are logged in. If you are logged in and still don't see the button, please contact us at unclcn@unc.edu or (919) 445–1000.
![]() | Anne W. Beaven, MD Associate Professor of Medicine |
Presenter Disclosure Information
Anne W. Beaven, MD, has no relevant financial relationships with commercial interests as defined by the ACCME.
The Greensboro Area Health Education Center is approved as a provider of nursing continuing professional development by the North Carolina Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.
Available Credit
- 1.00 ACPE Pharmacist
Accreditation Council for Pharmacy Education
The University of North Carolina Eshelman School of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. To receive CE credit, participants must complete the CE attendance form and the online evaluation of the program (instructions to be emailed). Statements of credit can be viewed and printed in CPE Monitor in approximately 2 to 3 weeks.
**No partial credit will be available**
- 1.00 ACPE Pharmacy Tech
Accreditation Council for Pharmacy Education
The University of North Carolina Eshelman School of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. To receive CE credit, participants must complete the CE attendance form and the online evaluation of the program (instructions to be emailed). Statements of credit can be viewed and printed in CPE Monitor in approximately 2 to 3 weeks.
**No partial credit will be available**
- 1.00 ASRT
Approved by the American Society of Radiologic Technologists (ASRT).
Tim Poe, Director of Telehealth
- 1.00 CTRApproved as a Category A by the National Cancer Registrars Association (NCRA).
- 1.00 NCPD/CNE
Greensboro Area Health Education Center is approved as a provider of nursing continuing professional development by the North Carolina Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation
Event Coordinator: Lisa Guy, RN, BSN, CCRN
- 1.00 Participation
UNC Lineberger Cancer Network certificate of participation.
Tim Poe, Director of Telehealth